Wang Y,Zhao H,Wang C,Zhang X,Tao J,Cui C .2020 .Incidence, predictors, and prognosis of coronary slow-flow and no-reflow phenomenon in patients with chronic total occlusion who underwent percutaneous coronary intervention. Ther Clin Risk Manag, 16 : 95-101.
Savic L,Mrdovic I,Asanin M,Stankovic S,Lasica R,Krljanac G .2022 .The impact of kidney function on the slow-flow/no-reflow phenomenon in patients treated with primary percutaneous coronary intervention: registry analysis. J Interv Cardiol, : 1-8.
Kai T,Oka S,Hoshino K,Watanabe K,Nakamura J,Abe M,Circ J. .2021 .Renal dysfunction as a predictor of slow-flow/no-reflow phenomenon and impaired ST segment resolution after percutaneous coronary intervention in ST-elevation myocardial infarction with initial thrombolysis in myocardial infarction grade 0. , 85 : 1770-8.
Khan MA,Samiullah JR,Shaikh JK,Butt MH,Hassan MU .2023 .Renal Dysfunction as a Predictor of Slow-Flow/No-Reflow Phenomenon and Impaired ST-Segment Resolution after Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction. A Retrospective Analysis. Pakistan J Med Heal Sci, 17 : 557-61.
Kalyoncuoglu M,Biter Hİ,Ozturk S,Belen E,Can MM .2020 .Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-tohigh-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-STelevated myocardial infarction. Coron Artery Dis, 31(6) : 518-26.
Kumar R,Khan KA,Shah JA,Ammar A,Kumar D,Khowaja S .2022 .Quantification of thrombus burden as an independent predictor of intra-procedural no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary revascularization. J Ayub Med Coll Abbottabad, 34 2 : 288-94.
Yang L,Cong H,Lu Y,Chen X,Liu Y. .2020 .Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Medicine (Baltimore), 99 : E20152.
Wang Q,Shen H,Mao H,Yu F,Wang H,Zheng J .2019 .Shock index on admission is associated with coronary slow/no reflow in patients with acute myocardial infarction undergoing emergent percutaneous coronary intervention. J Interv Cardiol, : 7873468.
Ashraf T,Khan MN,Afaque SM,Aamir KF,Kumar M,Saghir T .2019 .Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention. Int J Cardiol, 294 : 27-31.
Kakar AW,Kumar A,Shaikh JK,Kalwar MH,Butt MH,Rizvi NH .2022 .Rate and determinants of slow flow / no-reflow in patients undergoing primary percutaneous coronary intervention at Sandaman provincial hospital Quetta. Pakistan J Med Heal Sci, 16 : 1057-61.
Hoai LT,Xuan DN,Duc HN,Tuan LN .2022 .Autologous blood injection intracoronary artery for treating slow-flow and no-reflow in acute coronary syndrome related to primary PCI. Clin Case Reports, 10(2) : e05328.
Søndergaard FT,Beske RP,Frydland M,Møller JE,Helgestad OK,Jensen LO .2023 .Soluble ST2 in plasma is associated with postprocedural no-or-slow reflow after primary percutaneous coronary intervention in ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care, 12(1) : 48-52.
Refaat H,Tantawy A,Gamal AS,Radwan H .2021 .Novel predictors and adverse long-term outcomes of no-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Indian Heart J, 73 : 35-43.
Savic L,Mrdovic I,Asanin M,Lasica R,Krljanac G,Rajic D .2023 .The impact of kidney function on the slow-flow/no-reflow phenomenon in patients treated with primary percutaneous coronary intervention: registry analysis. Eur Hear J Acute Cardiovasc Care, 12(Supplement) : zuad036-042.